Altria Invests $2 Billion in Cronos Group Cannabis, an Industrial Info Market Brief
Altria Invests $2 Billion in Cronos Group Cannabis, an Industrial Info Market Brief
Attachment: cannabis2
The lines are getting blurry between medicinal and recreational, as cannabis companies enter the big leagues. The latest deal is Marlboro owner Altria investing nearly $2 billion in the Cronos Group (CRON), one of the early legitimate players in the cannabis market. Industrial Info has been tracking cannabis production facilities throughout the globe since the first hints of legalization began to emerge. There is nearly $2.4 billion in reported project activity, with much more to follow. Traditional pharma-bio industry suppliers and vendors are finding this a viable market in which to serve, with its expanding need for automation and standardized production equipment and processes.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects